Lun - Ven 8:00 - 17:00
So that was about two extra happy times a month. So that's one over placebo, per month. So the FDA didn't think that was very impressive.
| Age Range | Percentage of Users | Main Reasons for Use | Average Duration of Use |
|---|---|---|---|
| 25-35 years | 40% | Mood improvement, libido boost | 3-6 months |
| 36-45 years | 35% | Menopause symptoms, energy enhancement | 6-12 months |
| 46-50 years | 25% | Hormonal support, sleep aid | Varies |
| All ages | N/A | General wellness | Ongoing |
What happened was the drug company that originally started flibanserin gave up the drug, and another small start up company called Sprout Pharmaceuticals took it on and they actually started a media campaign called Even the Score. They went to the FDA and said, "Women have nothing.
So they had this drug and they did a randomized trial where women were given placebo versus this drug at different doses and lo and behold, there was sex medicine a little difference. Now I want to talk about, if I were going to counsel a patient, what kind of difference was there with flibanserin? It turns out about 10% of women respond. So if you give this drug to 100 women, and you give placebo to 100 women, 34 out of 100 of women with placebo will get better, they'll have more interest in sex and they'll have more sexually satisfying sexual activity. So out of 100 people, about 10 will actually be responding because of the drug, and we don't know when I'm sitting in the office, which 10% those are. Men have all these things to help them, women have nothing. So the FDA originally didn't think that one extra happy time per month was adequate given the side effects, which I'll talk about in a second. Then I think they got some pressure and they decided okay, we'll just put it out, and it's going to be available under the brand name Addyi, with a funny spelling A-D-D-Y-I, Addyi, on the middle of October. It should be available in drug stores. You have to take it every day, you have to take it at bedtime and so different from the Viagra style drugs for men, they only take it when they think they're going to be interested in sex. Women have to take this every day, so they're taking a pill every day for an event that might happen three or four times a month.
| Benefit | Description | Evidence Level | Common Side Effects |
|---|---|---|---|
| Mood Stabilization | Helps reduce anxiety and improve mood | Moderate | Headaches, nausea |
| Increased Libido | Boosts sexual desire | Anecdotal, some studies | Fatigue, dizziness |
| Better Sleep | Promotes better quality sleep | Consistent reports | Drowsiness, dry mouth |
| Energy Boost | Provides a natural increase in daytime alertness | Limited clinical data | Jitters, insomnia |
What are the side effects and why do you take it at bedtime? You take it at bedtime because the side effects include low blood pressure, hypotension, fainting, dizziness, headache and sleepiness.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Kamagra 100 mg | 100 mg | 84 + 6 Pills | 264.44€ 251.85€ | |
| Viagra Original | 100mg | 8 Pills | 59.84€ 56.99€ | |
| Viagra Generic | 50mg | 10 Pills | 26.87€ 25.59€ | |
| Levitra Original | 20mg | 76 + 4 Pills | 344.39€ 327.99€ | |
| Cialis Generic | 2.5mg | 60 + 4 Pills | 83.43€ 79.46€ | |
| Levitra Generic | 20mg | 120 + 10 Pills | 224.15€ 213.48€ | |
| Kamagra Oral Jelly | 100mg | 220 + 18 Sachets | 662.24€ 630.70€ | |
| Kamagra 100 mg | 100 mg | 120 + 6 Pills | 330.74€ 314.99€ | |
| Viagra Generic | 150mg | 270 + 10 Pills | 326.61€ 311.06€ | |
| Levitra Generic | 60mg | 30 + 2 Pills | 109.43€ 104.22€ | |
| Kamagra Oral Jelly | 100 mg | 10 Sachets | 54.55€ 51.95€ | |
| Cialis Original | 20mg | 22 + 2 Pills | 129.20€ 123.05€ |
About 10% of women are going to have that effect. So 10% of women are going to have a benefit, 10% of women are going to have a side effect. We don't know if it's the same 10%.
So they recommend taking it at bedtime so that you're less likely to be dizzy or to pass out, so I think that's the issue. I'm glad that women have something that might work for them, and like birth control methods, not all methods are right for everyone. They recommend that if a woman takes it for eight weeks and she doesn't notice a difference, remember that half the difference that she notices is going to be placebo effect. So if she doesn't notice a difference then she shouldn't take it anymore. It's going to be $30-$75 per month and we don't know whether insurance companies are going to cover it. But you can bet your booties that if insurance companies cover the Viagra type drugs and they don't cover Addyi, there's going to be some ladies marching on your insurance company's front door.
But then the question you ask is, "How much does this distress you?" and you say, "Well I don't care, it's fine by me. My husband is a little tweaked about it, but fine," or, "This has really destroyed our relationship. My husband is looking forward to the kind of closeness we had early in our relationship, the intimacy, frequency, and now, it's not there." So although not having desire is normal for women, if it was a change in desire and if it causes distress, should we medicate that? My feeling for a patient who comes to me with this complaint, and about 10% of women have this condition, where they have a decrease in their desire and it causes them distress. Those are the two things you have to have.
And for women for whom it causes distress, we have not had anything that works. "Take a couple of drinks and see how you feel." Or, we tried testosterone patches and that's a whole separate issue and that didn't make a big difference, so we really didn't have anything. Guys had a whole menu of things that could work on erectile dysfunction. Now, erectile dysfunction is not desire disorder. It means you've got desire and it doesn't work and the purple little, blue pill, Viagra, is one of a series of drugs which increase blood flow to the penis, and when you give those kinds of drugs to women, nothing happens.
They get more blood flow down there but they're not excited. So to call this female Viagra is way wrong. Interviewer: Because Viagra solves a mechanical problem. Dr. Jones: Exactly, and in women it's an internal desire problem. Interviewer: So there are a lot of pills for men, as you mentioned, this is really the only one for women. Is there a medical reason for that?
Jones, we've been reading much, as I would imagine our listeners have and seen the news coverage on the little pink pill, it's being called "the female Viagra" which is probably not accurate and we'll talk about that in a second as well. How would you decide whether or not you would recommend it or not recommend it to a patient? There are benefits, there are drawbacks, the FDA didn't approve it twice and now they've approved it, just a lot of questions. So first of all what is this pill and what does it do? Some years ago a drug company in Europe was looking for a new, better anti-anxiety and anti-depressant drug that wouldn't have sexual side effects.
A lot of the drugs in the SSRI group can cause problems with libido. So they have this drug called flibanserin and they rolled it out, looking at it as an anti-depressant and they found that in men it didn't change their libido one way or the other and it didn't work that great as an anti-depressant. But in women it wasn't that great as an anti-depressant, but it actually had a little boost in sexual interest. So they then went on to say, "We'll take this drug which works on the neurotransmitters in the brain," so this works on dopamine, it increases dopamine, the reward center. It increases norepinephrine, another rewards center and it decreases serotonin.
So they decided they'd work on it and see how it really worked in women who complained of hypoactive sexual desire disorder. Is this a disease or do women, when they get to a certain part of life, is not having much of a sex drive perfectly normal and the answer is it's so common, that yes, it's normal. It's been suggested that as many of 40% of women at some time in their life have a period of time of two weeks when they're not interested in sex. So if I ask women, "Has there been a time in the last year for longer than two weeks when you weren't interested in sex?" Most women are going to respond, "Oh shoot yeah. Not being interested in sex isn't a disease. Is it more difficult to create a drug, or is it what a lot of people claim that it's a man's world and I don't even know the words, but that argument. Dr.
| Side Effect | Description | Risk Factors | Recommendations |
|---|---|---|---|
| Nausea | Feeling of sickness after intake | Sensitive stomachs | Take with food |
| Headaches | Mild to moderate headaches | Dehydration, stress | Stay hydrated, reduce stress |
| Hormonal Disruption | Imbalance caused by hormonal ingredients | Overuse, interaction with medications | Consult a doctor before use |
| Allergic Reactions | Rash, swelling, itching | Allergies to herbal ingredients | Discontinue use, seek medical help |
Jones: Well it's been unfortunate that we've considered men so simple.
All they need is something to make their switch go up instead of down and that should be very easy. Whereas women, desire is a complicated thing.
The advocacy group called “Even the Score” had a large presence at the FDA approval committee meeting. Their campaign supports gender equality when it pertains to drugs to treat sexual dysfunction. Many are concerned that the FDA has a gender bias when it comes to approving drugs for women. Currently the FDA has approved 26 medications that treat male sexual dysfunction and none that treat women’s. It acts on the dopamine and serotonin receptors in the brain.
Thus, only women with a dopamine and serotonin imbalance are candidates for this drug. This is not for everyone and only upon completion of a thorough examination should a woman with the diagnosis of Hypoactive Sexual Desire Disorder be prescribed this medication. (That is, assuming the FDA actually approves it.) If approved, “the little pink pill” will be as popular a term as the “little blue pill” has been for men. Interviewer: The little pink pill that helps women's sex drive. We're going to ask Dr.
Kirtly Parker Jones to tell us more about that next on The Scope. Announcer: Covering all aspects of women's health. This is the "Seven Domains of Women's Health" with Dr. Kirtly Jones, on The Scope. Interviewer: Dr. We don't know how flibanserin works, if it does, and why it only works for 10% and not on the others, because we don't know where desire comes from in women. Why is it common, 50% of women don't have desire until they're already in the middle of being stimulated, so they only have responsive desire? So we're not very smart about where desire comes from, and there aren't very many good animal models for desire. Interviewer: What would you recommend to a patient asking you about this medication? Dr. Jones: I think I'm a fan of the 5 Ts, so when a woman says I'm just not that interested in sex anymore and this bothers me, remember those are the two things. They have to be not as interested, they have to have had interest at least once, so taking a 50-year-old who's never been interested in sex and thinking a pill is going to work, it's not going to work.
It's a drug that you have to take every day and it has side effects. But what can you expect if you are one of those 10%, what can you expect to see in terms of difference? Well the other reason the FDA was not excited was the fact that the average number of satisfying sexual activities was 2.8 in the study group and when they took placebo it went to 3.7 per month, 2.7 happy times in bed per month. And then with placebo, it went to 3.7. So about one extra happy time when you just took placebo, and it went from 2.8 on flibanserin before they started, to 4.5 on flibanserin. "So I had interest and now I don't." I say the 5 Ts are, Time - we are over extended. If you think you're going to have fast food sex the way you did when you were 20 you're not going to. You need to go for gourmet sex which means you have to plan it, you have to think about it, you have to tell your partner what makes you get in the mood.
Années d'expérience
Domaines d'interventions
Dans le cadre de notre stratégie, nous menons des actions locales dans les différentes écorégions cruciales, en visant des objectifs globaux.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Parce que chaque espèce joue un rôle particulier dans l’écosystème, elle est précieuse
En savoir plus
L'éducation environnementale sensibilise, surtout les jeunes, à nos ressources et à leur usage durable.
En savoir plus
L'écotourisme préserve la nature, implique les communautés locales et offre des expériences durables.
En savoir plus
Moins dépendance forestière, plus de sécurité alimentaire, préservation des ressources.
En savoir plusNos Projets
ODDB-ONG mène des actions écologiques pour soutenir les populations locales dans leurs efforts pour améliorer leur bien-être et celui de leur environnement.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Question à nous poser
Nos Statistiques
Années d'expérience
de superficies reboisées
personnes sensibilisées
personnes autonomisées
Stagiaires et bénévoles formés pour suivi de la biodiversité
Nos Actualités